Paving the Way for Respiratory Syncytial Virus Prevention: Vaccine Development Against a Widespread Cause of Respiratory Illness in Infants and Young Children

This fact sheet highlights PATH's work to develop a vaccine against respiratory syncytial virus (RSV) for use in a maternal immunization strategy in the developing world that can protect infants in the critical early months of life.

Publication date: September 2013

Paving the Way for Respiratory Syncytial Virus Prevention

93 KB PDF

Hard copies are not available.

View Resource